Leo Cancer Care Brings Into Clinical Use an Upright Radiotherapy Platform Cleared for Use With Any Radiation Beam

RegulatoryapprovedUpright PlatformPositive

AI Analysis

Summary

Leo Cancer Care announced its Upright Platform for radiotherapy has received clearance for clinical use, marking the transition of upright radiotherapy from concept to clinical application. The platform is designed to be beam-agnostic and compatible with various radiation beam types.

Outcome Details

Upright radiotherapy platform cleared for clinical use, beam-agnostic design

Importance:6/10

Sentiment:

0.70

radiotherapyoncologyplatform technologyregulatory clearance

Related Companies

$DFPH $BEAM

Read the original article

Published by PR Newswire Biotech on September 27, 2026 12:00 PM

Read Original